data_1mit_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mit _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 108.882 -1.687 . . . . 5.9199999999999999 108.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 2' ' ' SER . 83.9 p -103.7 -128.56 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.376 -0.93 . . . . 4.8799999999999999 109.913 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 1' ' ' SER . 12.0 p -103.95 122.3 44.92 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.451 -0.9 . . . . 3.29 109.921 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.906 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 74.1 m -81.15 175.57 4.7 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.384 -0.926 . . . . 1.22 109.908 179.965 -63.252 137.651 33.183 104.226 2.019 103.901 -179.686 -62.173 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.906 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 14.7 Cg_exo -57.79 148.2 76.38 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.368 2.045 . . . . 2.0299999999999998 110.648 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.845 ' HA3' ' ND2' ' A' ' 28' ' ' ASN . . . 89.99 172.45 44.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.418 -1.473 . . . . 1.4399999999999999 109.418 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.916 ' HD2' ' HB3' ' A' ' 27' ' ' GLN . 12.7 tttm -48.69 125.01 9.26 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.376 -0.93 . . . . 1.45 109.866 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.45 -15.17 24.48 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.448 -0.901 . . . . 2.3900000000000001 109.982 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 91.0 p -159.59 138.95 11.24 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.335 -0.946 . . . . 1.5800000000000001 110.118 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.742 ' O ' ' HB3' ' A' ' 65' ' ' PRO . 3.5 m-90 -98.79 163.27 19.2 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.46 -0.896 . . . . 0.72999999999999998 109.737 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.439 ' HD3' ' NZ ' ' A' ' 6' ' ' LYS . 11.0 Cg_endo -68.31 -99.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.29 1.993 . . . . 0.81000000000000005 110.174 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -146.3 82.04 1.59 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.51 -0.876 . . . . 4.1200000000000001 109.614 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.845 ' HA ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -92.31 7.32 43.32 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.341 -0.944 . . . . 2.1499999999999999 110.198 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.768 HG23 ' HA ' ' A' ' 62' ' ' VAL . 42.9 t -67.56 127.97 30.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.16 -1.016 . . . . 1.6499999999999999 109.784 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.83 -0.1 79.06 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.01 -1.636 . . . . 1.3200000000000001 109.01 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.845 HG22 ' HA ' ' A' ' 12' ' ' LEU . 1.3 t -96.44 15.24 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.382 -0.927 . . . . 2.0899999999999999 109.648 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 61' ' ' VAL . . . 77.55 131.45 0.54 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.413 -1.475 . . . . 2.2999999999999998 109.413 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.654 ' N ' HG23 ' A' ' 61' ' ' VAL . . . -51.45 -32.0 29.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.419 -1.472 . . . . 2.04 109.419 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -65.57 0.67 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.337 -0.945 . . . . 1.6799999999999999 109.819 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 23' ' ' ILE . 12.4 t -49.92 -47.86 22.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.938 . . . . 1.71 109.649 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.0 80.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.432 -0.907 . . . . 1.52 109.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.845 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 15.1 tttp -60.18 -48.18 82.8 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.444 -0.902 . . . . 1.8200000000000001 109.683 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.52 64.68 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.381 -0.928 . . . . 1.1599999999999999 109.848 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.6 mt -66.7 -43.83 89.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.476 -0.89 . . . . 1.3300000000000001 109.999 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.062 HG22 ' HB ' ' A' ' 51' ' ' VAL . 36.4 mt -61.25 -37.65 78.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.916 . . . . 1.1299999999999999 110.073 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.99 -46.39 44.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.346 -0.941 . . . . 1.5900000000000001 110.074 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -74.89 -19.54 60.1 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.433 -0.907 . . . . 4.0899999999999999 109.872 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.916 ' HB3' ' HD2' ' A' ' 6' ' ' LYS . 9.8 mm-40 -90.16 -32.35 16.68 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.443 -0.903 . . . . 2.1099999999999999 109.798 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.989 ' HB3' HG23 ' A' ' 31' ' ' VAL . 19.4 t-20 -151.92 90.6 3.85 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.466 -0.893 . . . . 0.68999999999999995 109.846 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -59.14 -9.71 8.77 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.352 2.034 . . . . 0.76000000000000001 110.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.6 m120 -96.61 1.17 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.311 -0.956 . . . . 2.0099999999999998 110.023 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.989 HG23 ' HB3' ' A' ' 28' ' ' ASN . 2.5 m -124.64 136.99 58.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.39 -0.924 . . . . 1.28 109.796 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -87.81 147.15 25.28 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.377 -0.929 . . . . 3.3599999999999999 109.958 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 24' ' ' ILE . . . -96.22 107.15 19.45 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.377 -0.929 . . . . 1.1799999999999999 109.697 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.792 ' HB ' ' HD2' ' A' ' 52' ' ' ARG . 2.1 t -96.39 154.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.287 -0.965 . . . . 1.46 109.968 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.723 ' O ' HD21 ' A' ' 36' ' ' LEU . 2.5 mt -140.17 100.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.333 -0.947 . . . . 1.51 109.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.784 HD22 HG13 ' A' ' 34' ' ' VAL . 1.1 mt -126.11 150.31 48.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.297 -0.961 . . . . 1.8200000000000001 109.769 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.927 ' HA ' HG23 ' A' ' 55' ' ' VAL . 8.5 mt-10 -68.31 133.36 48.64 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.171 -1.012 . . . . 2.4199999999999999 108.915 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HA ' ' CE3' ' A' ' 54' ' ' TRP . 6.9 tt0 -43.35 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.31 -0.956 . . . . 2.3399999999999999 110.318 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 139.6 -16.57 3.1 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.151 -1.499 . . . . 1.25 109.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.733 ' H ' ' HZ3' ' A' ' 54' ' ' TRP . 5.5 m -50.94 113.59 3.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 119.438 -0.905 . . . . 2.2999999999999998 109.858 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -56.71 94.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.245 1.963 . . . . 2.52 110.303 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.743 HG23 ' NH2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.85 -169.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.483 -0.887 . . . . 2.3199999999999998 109.894 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.449 ' H ' ' HG1' ' A' ' 43' ' ' THR . 1.6 m -66.67 179.29 1.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.364 -0.934 . . . . 3.4399999999999999 109.836 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -37.67 6.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.383 -0.927 . . . . 6.5700000000000003 110.121 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.51 136.26 40.62 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.359 -0.937 . . . . 3.7000000000000002 110.098 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -103.86 149.68 24.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.498 -0.881 . . . . 5.1500000000000004 109.871 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HB2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -117.15 135.41 53.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.258 -0.977 . . . . 5.0999999999999996 110.145 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 71.8 m -63.72 -5.79 4.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.48 -0.888 . . . . 1.26 109.978 -179.97 -62.173 -179.686 33.183 103.901 2.019 104.226 137.651 -63.252 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.679 ' ND2' ' HG3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -105.24 26.95 8.74 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.334 -0.946 . . . . 2.1000000000000001 109.43 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.679 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 20.3 mtp85 -152.73 98.98 2.4 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.052 -1.059 . . . . 2.2400000000000002 110.909 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.062 ' HB ' HG22 ' A' ' 24' ' ' ILE . 2.5 t -79.5 103.27 6.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.301 -1.37 . . . . 1.29 107.301 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.792 ' HD2' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.5 99.65 7.35 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 124.141 0.901 . . . . 1.3899999999999999 111.146 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.777 HG22 ' HB3' ' A' ' 63' ' ' SER . 0.7 OUTLIER -88.33 142.33 13.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.55 -0.907 . . . . 1.53 108.55 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.747 ' O ' HG21 ' A' ' 62' ' ' VAL . 48.3 m95 -130.51 163.75 26.36 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.642 -1.223 . . . . 0.71999999999999997 110.749 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.927 HG23 ' HA ' ' A' ' 37' ' ' GLU . 3.2 m -118.93 127.97 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 124.085 0.865 . . . . 1.3100000000000001 109.403 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.822 ' ND2' ' HB2' ' A' ' 58' ' ' ARG . 29.7 p-10 -84.47 136.75 33.71 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.129 -1.028 . . . . 2.0 109.984 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 59' ' ' GLY . 1.6 pttp -43.38 -23.94 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.247 0.967 . . . . 3.8599999999999999 110.274 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.822 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 1.1 mmp_? -56.38 -5.11 0.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.227 -0.989 . . . . 3.7200000000000002 109.711 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 57' ' ' LYS . . . 86.61 36.34 9.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.264 -1.534 . . . . 1.29 109.264 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.597 ' HB2' ' OD1' ' A' ' 56' ' ' ASN . 2.0 mp -137.69 171.66 14.12 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.089 -1.044 . . . . 1.6899999999999999 110.361 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 66.4 t -107.05 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.489 -0.884 . . . . 1.3100000000000001 109.939 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.768 ' HA ' HG23 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -85.25 84.35 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.446 -0.902 . . . . 1.48 110.082 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.777 ' HB3' HG22 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -90.1 107.14 17.44 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.387 -0.925 . . . . 1.9299999999999999 109.646 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.702 ' HD3' ' O ' ' A' ' 62' ' ' VAL . 15.0 Cg_exo -57.42 102.85 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.235 1.956 . . . . 1.05 110.356 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.743 ' HD3' ' O ' ' A' ' 63' ' ' SER . 9.8 Cg_exo -63.61 22.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.672 2.248 . . . . 1.01 111.389 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' H ' ' C ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -148.2 122.03 9.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.163 -1.015 . . . . 3.8300000000000001 109.887 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER -80.6 157.56 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.394 -0.922 . . . . 2.0299999999999998 109.927 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 116.313 -2.382 . . . . 2.48 109.454 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 108.882 -1.687 . . . . 5.5899999999999999 108.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 2' ' ' SER . 83.9 p -103.7 -128.56 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.376 -0.93 . . . . 4.7400000000000002 109.913 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 1' ' ' SER . 12.0 p -103.95 122.3 44.92 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.451 -0.9 . . . . 2.9100000000000001 109.921 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.909 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 74.1 m -81.15 175.57 4.7 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.384 -0.926 . . . . 1.1799999999999999 109.908 179.965 -63.252 137.651 33.183 104.226 2.019 103.901 -179.686 -62.173 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.909 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 14.7 Cg_exo -57.79 148.2 76.38 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.368 2.045 . . . . 1.72 110.648 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.713 ' HA3' ' OD1' ' A' ' 28' ' ' ASN . . . 89.99 172.45 44.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.418 -1.473 . . . . 0.93000000000000005 109.418 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.937 ' HD2' ' HB3' ' A' ' 27' ' ' GLN . 12.7 tttm -48.69 125.01 9.26 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.376 -0.93 . . . . 0.98999999999999999 109.866 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.45 -15.17 24.48 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.448 -0.901 . . . . 1.9099999999999999 109.982 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 91.0 p -159.59 138.95 11.24 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.335 -0.946 . . . . 1.23 110.118 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.775 ' CH2' HG21 ' A' ' 51' ' ' VAL . 3.5 m-90 -98.79 163.27 19.2 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.46 -0.896 . . . . 0.62 109.737 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' HD21 ' A' ' 12' ' ' LEU . 11.0 Cg_endo -68.31 -99.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.29 1.993 . . . . 0.79000000000000004 110.174 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 10' ' ' PRO . 2.6 t60 -146.3 82.04 1.59 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.51 -0.876 . . . . 3.3100000000000001 109.614 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -92.31 7.32 43.32 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.341 -0.944 . . . . 1.7 110.198 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 42.9 t -67.56 127.97 30.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.16 -1.016 . . . . 1.04 109.784 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.83 -0.1 79.06 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.01 -1.636 . . . . 1.22 109.01 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 12' ' ' LEU . 1.3 t -96.44 15.24 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.382 -0.927 . . . . 1.52 109.648 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.627 ' C ' HG21 ' A' ' 61' ' ' VAL . . . 77.55 131.45 0.54 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.413 -1.475 . . . . 1.51 109.413 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.885 ' N ' HG21 ' A' ' 61' ' ' VAL . . . -51.45 -32.0 29.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.419 -1.472 . . . . 1.4199999999999999 109.419 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -65.57 0.67 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.337 -0.945 . . . . 1.1799999999999999 109.819 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.701 ' O ' HG13 ' A' ' 23' ' ' ILE . 12.4 t -49.92 -47.86 22.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.938 . . . . 1.0900000000000001 109.649 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.0 80.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.432 -0.907 . . . . 0.79000000000000004 109.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.04 ' NZ ' ' HB3' ' A' ' 33' ' ' ALA . 15.1 tttp -60.18 -48.18 82.8 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.444 -0.902 . . . . 1.24 109.683 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.52 64.68 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.381 -0.928 . . . . 0.5 109.848 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.6 mt -66.7 -43.83 89.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.476 -0.89 . . . . 0.66000000000000003 109.999 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.879 HG21 ' HB ' ' A' ' 51' ' ' VAL . 36.4 mt -61.25 -37.65 78.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.916 . . . . 0.46000000000000002 110.073 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.99 -46.39 44.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.346 -0.941 . . . . 1.5900000000000001 110.074 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -74.89 -19.54 60.1 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.433 -0.907 . . . . 3.3700000000000001 109.872 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.937 ' HB3' ' HD2' ' A' ' 6' ' ' LYS . 9.8 mm-40 -90.16 -32.35 16.68 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.443 -0.903 . . . . 1.52 109.798 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.847 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -151.92 90.6 3.85 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.466 -0.893 . . . . 0.60999999999999999 109.846 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -59.14 -9.71 8.77 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.352 2.034 . . . . 0.69999999999999996 110.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.6 m120 -96.61 1.17 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.311 -0.956 . . . . 1.3899999999999999 110.023 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 28' ' ' ASN . 2.5 m -124.64 136.99 58.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.39 -0.924 . . . . 0.66000000000000003 109.796 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -87.81 147.15 25.28 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.377 -0.929 . . . . 2.75 109.958 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.04 ' HB3' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.22 107.15 19.45 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.377 -0.929 . . . . 0.60999999999999999 109.697 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 52' ' ' ARG . 2.1 t -96.39 154.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.287 -0.965 . . . . 0.82999999999999996 109.968 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.79 ' C ' HD23 ' A' ' 36' ' ' LEU . 2.5 mt -140.17 100.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.333 -0.947 . . . . 0.81999999999999995 109.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.79 HD23 ' C ' ' A' ' 35' ' ' ILE . 1.1 mt -126.11 150.31 48.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.297 -0.961 . . . . 1.21 109.769 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.982 ' HA ' HG22 ' A' ' 55' ' ' VAL . 8.5 mt-10 -68.31 133.36 48.64 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.171 -1.012 . . . . 2.4199999999999999 108.915 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HA ' ' CE3' ' A' ' 54' ' ' TRP . 6.9 tt0 -43.35 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.31 -0.956 . . . . 2.3399999999999999 110.318 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 139.6 -16.57 3.1 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.151 -1.499 . . . . 1.01 109.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.754 ' H ' ' HZ3' ' A' ' 54' ' ' TRP . 5.5 m -50.94 113.59 3.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 119.438 -0.905 . . . . 1.79 109.858 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -56.71 94.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.245 1.963 . . . . 2.1699999999999999 110.303 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.875 HG21 ' NH2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.85 -169.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.483 -0.887 . . . . 1.9199999999999999 109.894 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -66.67 179.29 1.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.364 -0.934 . . . . 2.9500000000000002 109.836 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -37.67 6.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.383 -0.927 . . . . 6.2400000000000002 110.121 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.51 136.26 40.62 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.359 -0.937 . . . . 3.7000000000000002 110.098 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' HD1' ' HA ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -103.86 149.68 24.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.498 -0.881 . . . . 4.3899999999999997 109.871 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HB2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -117.15 135.41 53.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.258 -0.977 . . . . 4.3200000000000003 110.145 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 71.8 m -63.72 -5.79 4.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.48 -0.888 . . . . 1.23 109.978 -179.97 -62.173 -179.686 33.183 103.901 2.019 104.226 137.651 -63.252 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.54 ' OD1' ' HG3' ' A' ' 50' ' ' ARG . 12.8 p-10 -105.24 26.95 8.74 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.334 -0.946 . . . . 1.46 109.43 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.662 HH21 HG22 ' A' ' 34' ' ' VAL . 20.3 mtp85 -152.73 98.98 2.4 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.052 -1.059 . . . . 1.74 110.909 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.879 ' HB ' HG21 ' A' ' 24' ' ' ILE . 2.5 t -79.5 103.27 6.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.301 -1.37 . . . . 0.52000000000000002 107.301 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.875 ' NH2' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.5 99.65 7.35 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 124.141 0.901 . . . . 1.1699999999999999 111.146 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.944 HG23 ' HB3' ' A' ' 63' ' ' SER . 0.7 OUTLIER -88.33 142.33 13.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.55 -0.907 . . . . 1.03 108.55 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.754 ' HZ3' ' H ' ' A' ' 40' ' ' THR . 48.3 m95 -130.51 163.75 26.36 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.642 -1.223 . . . . 0.62 110.749 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.982 HG22 ' HA ' ' A' ' 37' ' ' GLU . 3.2 m -118.93 127.97 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 124.085 0.865 . . . . 0.54000000000000004 109.403 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.827 ' ND2' ' HB2' ' A' ' 58' ' ' ARG . 29.7 p-10 -84.47 136.75 33.71 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.129 -1.028 . . . . 1.47 109.984 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' GLY . 1.6 pttp -43.38 -23.94 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.247 0.967 . . . . 3.4100000000000001 110.274 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.827 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 1.1 mmp_? -56.38 -5.11 0.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.227 -0.989 . . . . 3.1499999999999999 109.711 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' LYS . . . 86.61 36.34 9.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.264 -1.534 . . . . 0.84999999999999998 109.264 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.597 ' HB2' ' OD1' ' A' ' 56' ' ' ASN . 2.0 mp -137.69 171.66 14.12 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.089 -1.044 . . . . 1.03 110.361 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.885 HG21 ' N ' ' A' ' 17' ' ' GLY . 66.4 t -107.05 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.489 -0.884 . . . . 0.68999999999999995 109.939 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.704 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -85.25 84.35 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.446 -0.902 . . . . 0.71999999999999997 110.082 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.944 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -90.1 107.14 17.44 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.387 -0.925 . . . . 1.4299999999999999 109.646 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.704 ' HD3' ' O ' ' A' ' 62' ' ' VAL . 15.0 Cg_exo -57.42 102.85 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.235 1.956 . . . . 0.92000000000000004 110.356 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.774 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 9.8 Cg_exo -63.61 22.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.672 2.248 . . . . 0.81999999999999995 111.389 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -148.2 122.03 9.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.163 -1.015 . . . . 3.2200000000000002 109.887 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER -80.6 157.56 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.394 -0.922 . . . . 1.53 109.927 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 116.313 -2.382 . . . . 2.3999999999999999 109.454 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 108.882 -1.687 . . . . 5.5899999999999999 108.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 2' ' ' SER . 83.9 p -103.7 -128.56 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.376 -0.93 . . . . 4.7400000000000002 109.913 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 1' ' ' SER . 12.0 p -103.95 122.3 44.92 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.451 -0.9 . . . . 2.9100000000000001 109.921 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.909 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 74.1 m -81.15 175.57 4.7 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.384 -0.926 . . . . 1.1799999999999999 109.908 179.965 -63.252 137.651 33.183 104.226 2.019 103.901 -179.686 -62.173 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.909 ' HD2' ' HB3' ' A' ' 3' ' ' CYS . 14.7 Cg_exo -57.79 148.2 76.38 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.368 2.045 . . . . 1.72 110.648 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.863 ' HA3' ' ND2' ' A' ' 28' ' ' ASN . . . 89.99 172.45 44.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.418 -1.473 . . . . 0.93000000000000005 109.418 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.937 ' HD2' ' HB3' ' A' ' 27' ' ' GLN . 12.7 tttm -48.69 125.01 9.26 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.376 -0.93 . . . . 0.98999999999999999 109.866 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.45 -15.17 24.48 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.448 -0.901 . . . . 1.9099999999999999 109.982 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 65' ' ' PRO . 91.0 p -159.59 138.95 11.24 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.335 -0.946 . . . . 1.23 110.118 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.775 ' CH2' HG21 ' A' ' 51' ' ' VAL . 3.5 m-90 -98.79 163.27 19.2 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.46 -0.896 . . . . 0.62 109.737 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' HD21 ' A' ' 12' ' ' LEU . 11.0 Cg_endo -68.31 -99.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.29 1.993 . . . . 0.79000000000000004 110.174 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 10' ' ' PRO . 2.6 t60 -146.3 82.04 1.59 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.51 -0.876 . . . . 3.3100000000000001 109.614 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -92.31 7.32 43.32 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.341 -0.944 . . . . 1.7 110.198 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 42.9 t -67.56 127.97 30.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.16 -1.016 . . . . 1.04 109.784 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.83 -0.1 79.06 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.01 -1.636 . . . . 1.22 109.01 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 12' ' ' LEU . 1.3 t -96.44 15.24 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.382 -0.927 . . . . 1.52 109.648 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.627 ' C ' HG21 ' A' ' 61' ' ' VAL . . . 77.55 131.45 0.54 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.413 -1.475 . . . . 1.51 109.413 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.885 ' N ' HG21 ' A' ' 61' ' ' VAL . . . -51.45 -32.0 29.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.419 -1.472 . . . . 1.4199999999999999 109.419 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -65.57 0.67 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.337 -0.945 . . . . 1.1799999999999999 109.819 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.701 ' O ' HG13 ' A' ' 23' ' ' ILE . 12.4 t -49.92 -47.86 22.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.938 . . . . 1.0900000000000001 109.649 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.0 80.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.432 -0.907 . . . . 0.79000000000000004 109.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.04 ' NZ ' ' HB3' ' A' ' 33' ' ' ALA . 15.1 tttp -60.18 -48.18 82.8 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.444 -0.902 . . . . 1.24 109.683 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.52 64.68 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.381 -0.928 . . . . 0.5 109.848 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.6 mt -66.7 -43.83 89.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.476 -0.89 . . . . 0.66000000000000003 109.999 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.879 HG21 ' HB ' ' A' ' 51' ' ' VAL . 36.4 mt -61.25 -37.65 78.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.411 -0.916 . . . . 0.46000000000000002 110.073 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -73.99 -46.39 44.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.346 -0.941 . . . . 1.5900000000000001 110.074 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -74.89 -19.54 60.1 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.433 -0.907 . . . . 3.3700000000000001 109.872 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.937 ' HB3' ' HD2' ' A' ' 6' ' ' LYS . 9.8 mm-40 -90.16 -32.35 16.68 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.443 -0.903 . . . . 1.52 109.798 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.863 ' ND2' ' HA3' ' A' ' 5' ' ' GLY . 19.4 t-20 -151.92 90.6 3.85 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 119.466 -0.893 . . . . 0.60999999999999999 109.846 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -59.14 -9.71 8.77 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.352 2.034 . . . . 0.69999999999999996 110.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.6 m120 -96.61 1.17 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.311 -0.956 . . . . 1.3899999999999999 110.023 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 28' ' ' ASN . 2.5 m -124.64 136.99 58.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.39 -0.924 . . . . 0.66000000000000003 109.796 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -87.81 147.15 25.28 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.377 -0.929 . . . . 2.75 109.958 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.04 ' HB3' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.22 107.15 19.45 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.377 -0.929 . . . . 0.60999999999999999 109.697 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 52' ' ' ARG . 2.1 t -96.39 154.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.287 -0.965 . . . . 0.82999999999999996 109.968 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.79 ' C ' HD23 ' A' ' 36' ' ' LEU . 2.5 mt -140.17 100.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.333 -0.947 . . . . 0.81999999999999995 109.938 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.79 HD23 ' C ' ' A' ' 35' ' ' ILE . 1.1 mt -126.11 150.31 48.31 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.297 -0.961 . . . . 1.21 109.769 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.982 ' HA ' HG22 ' A' ' 55' ' ' VAL . 8.5 mt-10 -68.31 133.36 48.64 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.171 -1.012 . . . . 2.4199999999999999 108.915 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HA ' ' CE3' ' A' ' 54' ' ' TRP . 6.9 tt0 -43.35 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.31 -0.956 . . . . 2.3399999999999999 110.318 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 139.6 -16.57 3.1 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.151 -1.499 . . . . 1.01 109.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.754 ' H ' ' HZ3' ' A' ' 54' ' ' TRP . 5.5 m -50.94 113.59 3.92 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 119.438 -0.905 . . . . 1.79 109.858 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -56.71 94.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.245 1.963 . . . . 2.1699999999999999 110.303 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.875 HG21 ' NH2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.85 -169.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.483 -0.887 . . . . 1.9199999999999999 109.894 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -66.67 179.29 1.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.364 -0.934 . . . . 2.9500000000000002 109.836 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -37.67 6.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.383 -0.927 . . . . 6.2400000000000002 110.121 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.51 136.26 40.62 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.359 -0.937 . . . . 3.7000000000000002 110.098 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' HD1' ' HA ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -103.86 149.68 24.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.498 -0.881 . . . . 4.3899999999999997 109.871 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.574 ' HB2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -117.15 135.41 53.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.258 -0.977 . . . . 4.3200000000000003 110.145 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 71.8 m -63.72 -5.79 4.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.48 -0.888 . . . . 1.23 109.978 -179.97 -62.173 -179.686 33.183 103.901 2.019 104.226 137.651 -63.252 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.694 ' ND2' ' HG3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -105.24 26.95 8.74 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.334 -0.946 . . . . 1.46 109.43 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.694 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 20.3 mtp85 -152.73 98.98 2.4 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.052 -1.059 . . . . 1.74 110.909 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.879 ' HB ' HG21 ' A' ' 24' ' ' ILE . 2.5 t -79.5 103.27 6.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.301 -1.37 . . . . 0.52000000000000002 107.301 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.875 ' NH2' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.5 99.65 7.35 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 124.141 0.901 . . . . 1.1699999999999999 111.146 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.944 HG23 ' HB3' ' A' ' 63' ' ' SER . 0.7 OUTLIER -88.33 142.33 13.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.55 -0.907 . . . . 1.03 108.55 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.754 ' HZ3' ' H ' ' A' ' 40' ' ' THR . 48.3 m95 -130.51 163.75 26.36 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.642 -1.223 . . . . 0.62 110.749 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.982 HG22 ' HA ' ' A' ' 37' ' ' GLU . 3.2 m -118.93 127.97 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 124.085 0.865 . . . . 0.54000000000000004 109.403 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.827 ' ND2' ' HB2' ' A' ' 58' ' ' ARG . 29.7 p-10 -84.47 136.75 33.71 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.129 -1.028 . . . . 1.47 109.984 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' GLY . 1.6 pttp -43.38 -23.94 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.247 0.967 . . . . 3.4100000000000001 110.274 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.827 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 1.1 mmp_? -56.38 -5.11 0.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.227 -0.989 . . . . 3.1499999999999999 109.711 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' LYS . . . 86.61 36.34 9.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.264 -1.534 . . . . 0.84999999999999998 109.264 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.597 ' HB2' ' OD1' ' A' ' 56' ' ' ASN . 2.0 mp -137.69 171.66 14.12 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.089 -1.044 . . . . 1.03 110.361 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.885 HG21 ' N ' ' A' ' 17' ' ' GLY . 66.4 t -107.05 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.489 -0.884 . . . . 0.68999999999999995 109.939 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.704 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -85.25 84.35 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.446 -0.902 . . . . 0.71999999999999997 110.082 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.944 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -90.1 107.14 17.44 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.387 -0.925 . . . . 1.4299999999999999 109.646 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.704 ' HD3' ' O ' ' A' ' 62' ' ' VAL . 15.0 Cg_exo -57.42 102.85 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.235 1.956 . . . . 0.92000000000000004 110.356 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.774 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 9.8 Cg_exo -63.61 22.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.672 2.248 . . . . 0.81999999999999995 111.389 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -148.2 122.03 9.33 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.163 -1.015 . . . . 3.2200000000000002 109.887 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER -80.6 157.56 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.394 -0.922 . . . . 1.53 109.927 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 116.313 -2.382 . . . . 2.3999999999999999 109.454 -179.983 . . . . . . . . 0 0 . 1 stop_ save_